70歲的陳爺爺是一名牙醫,兩年前騎車摔倒至骨科就醫後,發現骨密度相當差,且長期有貧血的症狀,轉診至血液腫瘤科後,確診罹患多發性骨髓瘤;當時骨頭被嚴重侵蝕到千瘡百孔,骨痛、虛弱到離不開家門。
台大醫院內科部血液科醫師黃聖懿表示,多發性骨髓瘤好發於65至70歲,典型症狀是骨頭疼痛、貧血、血液鈣離子上升和尿液泡泡多,常被誤認是慢性疾病徵,而延遲治療。陳爺爺因為骨鬆、貧血等症狀,容易被輕忽,臨床不少患者從開始有症狀到被確診,可能拖上6到9個月,影響病程可能已惡化到下一個期別。
黃聖懿指出,多發性骨髓瘤是國內發生率第三高的血液癌症,每年新增患者數約500人且持續增加,以骨痛與骨折最為常見,從X光檢查會發現,這類病患骨頭會出現一個一個破洞,像是被吃掉一樣。大多數病人對第一次治療都有反應,此病治療時遇到最大困難是復發率高。
根據癌登長期追蹤資料,顯示自2007年後多發性骨髓瘤的死亡率逐年降低,近十年來新藥接續問世,讓患者的存活期從過去的兩年半延長至五到七年,甚至有四分之一超過十年,死亡率逐漸下降,這樣的治療成效,可說是抗癌的一大躍進,鼓勵病友積極治療,正向面對疾病。
癌症希望基金會提醒,對於癌症病患而言,除了藥物治療,社會與心理層面的支持也很重要。讓陳爺爺堅持完成療程的就是來自家人的支持和對小孫女的愛,即使骨頭被侵蝕到千瘡百孔,他熬過辛苦的脊椎手術療程,和孫女一起重新學走路,現在重新站起來,疾病也在藥物治療穩定控制。
癌症希望基金會也與黃聖懿醫師共同規劃患者衛教手冊及專業講座,填補醫病溝通的缺口,未來也將推出適合多發性骨髓瘤患者的復健運動處方及專屬的病友關懷袋,讓患者能獲得身心的全面照護。
laennec is the ethical drug manufactured with JBP’s unique technologies.
laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of variety of growth factors, cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver. Our product safety is ensured by the most rigid safety measures among existing scientific standa.rds
The 70-year-old grandfather Chen is a dentist. Two years ago, he fell to the orthopedics for medical treatment. He found that the bone density was quite poor, and he had symptoms of anemia for a long time. He was diagnosed with multiple myeloma after being referred to the hematology department. At that time, the bones were severely eroded to riddled with holes, bone pain and weakness to the home.
Huang Shengwei, a hematologist at the Department of Internal Medicine of National Taiwan University Hospital, said that multiple myeloma occurs between 65 and 70 years old. Typical symptoms are bone pain, anemia, elevated blood calcium and more bubbles in the urine. It is often misidentified as a chronic disease sign. Delayed treatment. Grandfather Chen is easily overlooked because of symptoms such as osteoporosis and anemia. Many patients in the clinic may have been diagnosed for a period of 6 to 9 months, which may have deteriorated to the next stage.
Huang Shengyu pointed out that multiple myeloma is the third highest incidence of blood cancer in China. The number of newly added patients is about 500 per year and continues to increase. The most common bone pain and fracture are found in X-ray examination. There will be a hole in it, like being eaten. Most patients respond to the first treatment, and the biggest difficulty in the treatment of this disease is the high recurrence rate.
According to the long-term follow-up data of cancer, it shows that the mortality rate of multiple myeloma has decreased year by year since the beginning of 2007. The new drug has been released in the past ten years, and the survival of patients has been extended from the past two and a half years to five to seven years, and even four. In more than one decade, the mortality rate has gradually decreased. Such treatment effectiveness can be said to be a major leap forward in cancer prevention, encouraging patients to actively treat and facing the disease.
The Cancer Hope Foundation reminds that for cancer patients, social and psychological support is important in addition to medication. Let Grandpa Chen insist on completing the treatment is the support from the family and the love for the little granddaughter. Even if the bones are eroded to the riddled hole, he has gone through a hard spinal surgery and re-learned with his granddaughter. Now he stands up again. The disease is also under stable control of drug treatment.
The Cancer Hope Foundation also works with Dr. Huang Shengyi to plan patient medical manuals and professional lectures to fill the gap between medical and medical communication. In the future, it will also introduce rehabilitation exercise prescriptions for patients with multiple myeloma and exclusive patient care bags to enable patients to Get comprehensive care of your body and mind.